Journal
New England Journal of Medicine
Publication Date
7-14-2022
Volume
387
Issue
2
First Page
148
Last Page
159
Document Type
Open Access Publication
DOI
10.1056/NEJMoa2119660
Rights and Permissions
Wu YW, Comstock BA, Gonzalez FF, Mayock DE, Goodman AM, Maitre NL, Chang T, Van Meurs KP, Lampland AL, Bendel-Stenzel E, Mathur AM, Wu TW, Riley D, Mietzsch U, Chalak L, Flibotte J, Weitkamp JH, Ahmad KA, Yanowitz TD, Baserga M, Poindexter BB, Rogers EE, Lowe JR, Kuban KCK, O'Shea TM, Wisnowski JL, McKinstry RC, Bluml S, Bonifacio S, Benninger KL, Rao R, Smyser CD, Sokol GM, Merhar S, Schreiber MD, Glass HC, Heagerty PJ, Juul SE; HEAL Consortium. Trial of Erythropoietin for Hypoxic-Ischemic Encephalopathy in Newborns. N Engl J Med. 2022 Jul 14;387(2):148-159. doi: 10.1056/NEJMoa2119660. Copyright © 2022 Massachusetts Medical Society. Reprinted with permission.
Recommended Citation
Wu, Yvonne W; McKinstry, Robert C; Rao, Rakesh; Smyser, Christopher D; and et al., "Trial of erythropoietin for hypoxic-ischemic encephalopathy in newborns." New England Journal of Medicine. 387, 2. 148 - 159. (2022).
https://digitalcommons.wustl.edu/oa_4/1030
Additional Links
Supplemental material is available for this article at publisher site.
